Estimands, Estimators and Sensitivity Analysis in Clinical Trials Estimands, Estimators and Sensitivity Analysis in Clinical Trials
Chapman & Hall/CRC Biostatistics Series

Estimands, Estimators and Sensitivity Analysis in Clinical Trials

Craig Mallinckrodt and Others
    • £44.99
    • £44.99

Publisher Description

The concepts of estimands, analyses (estimators), and sensitivity are interrelated. Therefore, great need exists for an integrated approach to these topics. This book acts as a practical guide to developing and implementing statistical analysis plans by explaining fundamental concepts using accessible language, providing technical details, real-world examples, and SAS and R code to implement analyses. The updated ICH guideline raises new analytic and cross-functional challenges for statisticians. Gaps between different communities have come to surface, such as between causal inference and clinical trialists, as well as among clinicians, statisticians, and regulators when it comes to communicating decision-making objectives, assumptions, and interpretations of evidence.

This book lays out a path toward bridging some of these gaps. It offers

A common language and unifying framework along with the technical details and practical guidance to help statisticians meet the challenges

A thorough treatment of intercurrent events (ICEs), i.e., postrandomization events that confound interpretation of outcomes and five strategies for ICEs in ICH E9 (R1)

Details on how estimands, integrated into a principled study development process, lay a foundation for coherent specification of trial design, conduct, and analysis needed to overcome the issues caused by ICEs:

A perspective on the role of the intention-to-treat principle

Examples and case studies from various areas

Example code in SAS and R

A connection with causal inference

Implications and methods for analysis of longitudinal trials with missing data

Together, the authors have offered the readers their ample expertise in clinical trial design and analysis, from an industrial and academic perspective.

GENRE
Professional & Technical
RELEASED
2019
23 December
LANGUAGE
EN
English
LENGTH
344
Pages
PUBLISHER
CRC Press
SIZE
20.3
MB
Quantitative Drug Safety and Benefit Risk Evaluation Quantitative Drug Safety and Benefit Risk Evaluation
2021
Cluster Randomised Trials Cluster Randomised Trials
2017
Advanced Statistical Analytics for Health Data Science with SAS and R Advanced Statistical Analytics for Health Data Science with SAS and R
2025
R for Health Technology Assessment R for Health Technology Assessment
2025
Design and Analysis of Clinical Trials with Time-to-Event Endpoints Design and Analysis of Clinical Trials with Time-to-Event Endpoints
2009
Generalized Linear Models Generalized Linear Models
2000